Viewing Study NCT03319459


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2026-02-20 @ 1:43 PM
Study NCT ID: NCT03319459
Status: COMPLETED
Last Update Posted: 2021-11-22
First Post: 2017-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
Sponsor: Fate Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module